Therapeutic Vasculogenesis

Therapeutic vasculogenesis: it takes two.

The shortage of organs for transplantation has been so severe and prolonged that many of us have become almost numb to the crisis facing patients and their families. In 2008, there are 98 992 patients on various organ transplantation waiting lists in the United States alone; during January and February, 4471 transplants were performed but 1044 patients died while on waiting lists.1 This organ c...

Angiogenesis and vasculogenesis for therapeutic neovascularization.

Peripheral blood of adult species contains endothelial progenitor cells (EPCs) that participate in neovascularization, consistent with postnatal vasculogenesis. EPCs can be isolated not only from peripheral blood but also from bone marrow and human umbilical cord blood. In vitro culture-expanded EPCs participate in endothelial network formation (capillary formation) in vitro, and transplanted E...

Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesis.

The vasculature is the first organ to arise during development. Blood vessels run through virtually every organ in the body (except the avascular cornea and the cartilage), assuring metabolic homeostasis by supplying oxygen and nutrients and removing waste products. Not surprisingly therefore, vessels are critical for organ growth in the embryo and for repair of wounded tissue in the adult. Not...

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.

Postnatal vasculogenesis

It is generally accepted that vasculogenesis is limited to early embryogenesis and is believed not to occur in adult, whereas angiogenesis occurs in both the developing embryo and postnatal life. However, the distinction between them is not absolute, because both require endothelial cell proliferation and migration and three-dimensional reorganization of newly formed blood vessels, nor are they...